Synthesis, 18F-Radiolabelling and Biological Characterization of Novel Fluoroalkylated Triazine Derivatives for in Vivo Imaging of Phosphodiesterase 2A in Brain via Positron Emission Tomography

Synthesis, 18F-Radiolabelling and Biological Characterization of Novel Fluoroalkylated Triazine Derivatives for in Vivo Imaging of Phosphodiesterase 2A in Brain via Positron Emission Tomography

Phosphodiesterase 2A (PDE2A) is highly and specifically expressed in particular brain regions that are affected by neurological disorders and in certain tumors. Development of a specific PDE2A radioligand would enable molecular imaging of the PDE2A protein via positron emission tomography (PET). Her...

Full description

Bibliographic Details
Main Authors:	Susann Schröder, Barbara Wenzel, Winnie Deuther-Conrad, Rodrigo Teodoro, Ute Egerland, Mathias Kranz, Matthias Scheunemann, Norbert Höfgen, Jörg Steinbach, Peter Brust
Format:	Article
Language:	English
Published:	MDPI AG 2015-05-01
Series:	Molecules
Subjects:	PDE2A Alzheimer’s disease PET imaging in brain micellar HPLC
Online Access:	http://www.mdpi.com/1420-3049/20/6/9591

Similar Items

Investigation of an 18F-labelled Imidazopyridotriazine for Molecular Imaging of Cyclic Nucleotide Phosphodiesterase 2A
by: Susann Schröder, et al.
Published: (2018-03-01)

Novel Radioligands for Cyclic Nucleotide Phosphodiesterase Imaging with Positron Emission Tomography: An Update on Developments Since 2012
by: Susann Schröder, et al.
Published: (2016-05-01)

Development of a New Radiofluorinated Quinoline Analog for PET Imaging of Phosphodiesterase 5 (PDE5) in Brain
by: Jianrong Liu, et al.
Published: (2016-04-01)

Challenges on Cyclic Nucleotide Phosphodiesterases Imaging with Positron Emission Tomography: Novel Radioligands and (Pre-)Clinical Insights since 2016
by: Susann Schröder, et al.
Published: (2021-04-01)

Radiosynthesis and Biological Investigation of a Novel Fluorine-18 Labeled Benzoimidazotriazine-Based Radioligand for the Imaging of Phosphodiesterase 2A with Positron Emission Tomography
by: Rien Ritawidya, et al.
Published: (2019-11-01)

Radiosynthesis and Preclinical Evaluation of an <sup>18</sup>F-Labeled Triazolopyridopyrazine-Based Inhibitor for Neuroimaging of the Phosphodiesterase 2A (PDE2A)
by: Barbara Wenzel, et al.
Published: (2022-10-01)

Radiosynthesis and Radiotracer Properties of a 7-(2-[18F]Fluoroethoxy)-6-methoxypyrrolidinylquinazoline for Imaging of Phosphodiesterase 10A with PET
by: Detlef Briel, et al.
Published: (2012-02-01)

Synthesis and In Vitro Evaluation of 8-Pyridinyl-Substituted Benzo[<i>e</i>]imidazo[2,1-<i>c</i>][1,2,4]triazines as Phosphodiesterase 2A Inhibitors
by: Rien Ritawidya, et al.
Published: (2019-07-01)

Genetic Association of Phosphodiesterases With Human Cognitive Performance
by: Mark E. Gurney
Published: (2019-02-01)

Neuroinflammation in Ischemic Stroke: Inhibition of cAMP-Specific Phosphodiesterases (PDEs) to the Rescue
by: Laura Ponsaerts, et al.
Published: (2021-06-01)

Clinical Implication of Phosphodiesterase-4-Inhibition
by: Martin Alexander Schick, et al.
Published: (2022-01-01)

Phosphodiesterase 1b (PDE1B) Regulates Spatial and Contextual Memory in Hippocampus
by: Susan McQuown, et al.
Published: (2019-02-01)

Phosphodiesterase-4 Inhibition in Psoriasis
by: Milakovic M, et al.
Published: (2021-03-01)

A Promising Biomolecule Able to Degrade Neutrophil Extracellular Traps: <i>Cdc</i>PDE, a Rattlesnake Phosphodiesterase
by: Isadora Oliveira, et al.
Published: (2023-01-01)

Differential effects of two phosphodiesterase 4 inhibitors against lipopolysaccharide-induced neuroinflammation in mice
by: Dong Ho Kang, et al.
Published: (2023-07-01)

Dominant-Negative Attenuation of cAMP-Selective Phosphodiesterase PDE4D Action Affects Learning and Behavior
by: Graeme B. Bolger, et al.
Published: (2020-08-01)

The Complexity and Multiplicity of the Specific cAMP Phosphodiesterase Family: PDE4, Open New Adapted Therapeutic Approaches
by: Claire Lugnier
Published: (2022-09-01)

Androgen Deficiency and Phosphodiesterase Type 5 Expression Changes in Aging Male: Therapeutic Implications
by: Antonio Aversa, et al.
Published: (2019-04-01)

Identification of phosphodiesterase-4 as the therapeutic target of arctigenin in alleviating psoriatic skin inflammation
by: Heng Li, et al.
Published: (2021-11-01)

Role of Phosphodiesterase 7 (PDE7) in T Cell Activity. Effects of Selective PDE7 Inhibitors and Dual PDE4/7 Inhibitors on T Cell Functions
by: Marianna Szczypka
Published: (2020-08-01)

PDE4 Phosphodiesterases in Cardiovascular Diseases: Key Pathophysiological Players and Potential Therapeutic Targets
by: Lídia Puertas-Umbert, et al.
Published: (2023-11-01)

Development of <sup>18</sup>F-Labeled Radiotracers for PET Imaging of the Adenosine A<sub>2A</sub> Receptor: Synthesis, Radiolabeling and Preliminary Biological Evaluation
by: Thu Hang Lai, et al.
Published: (2021-02-01)

Phosphodiesterase-4 Inhibition in the Management of Psoriasis
by: Erika L. Crowley, et al.
Published: (2023-12-01)

Phosphodiesterase 4B: Master Regulator of Brain Signaling
by: Amy J. Tibbo, et al.
Published: (2020-05-01)

Characterization and Modification of Light-Sensitive Phosphodiesterases from Choanoflagellates
by: Yuehui Tian, et al.
Published: (2022-01-01)

Editorial: Phosphodiesterases as Drug Targets in Airway and Inflammatory Diseases
by: Juraj Mokry, et al.
Published: (2021-04-01)

Phosphodiesterase 4 Inhibitors in Allergic Rhinitis/Rhinosinusitis
by: Viera Janosova, et al.
Published: (2020-07-01)

A tandem motif-based and structural approach can identify hidden functional phosphodiesterases
by: Mateusz Kwiatkowski, et al.
Published: (2021-01-01)

Recreation use of phosphodiesterase type 5 inhibitors, the other side of erectile dysfunction
by: Giovanni Maria Fusco, et al.
Published: (2023-05-01)

Role of Phosphodiesterase 1 in the Regulation of Real-Time cGMP Levels and Contractility in Adult Mouse Cardiomyocytes
by: Nadja I. Bork, et al.
Published: (2023-12-01)

Role of Cyclic Nucleotide Phosphodiesterases in Inner Ear and Hearing
by: Rahul Mittal, et al.
Published: (2017-11-01)

PET Imaging of the Adenosine A<sub>2A</sub> Receptor in the Rotenone-Based Mouse Model of Parkinson’s Disease with [<sup>18</sup>F]FESCH Synthesized by a Simplified Two-Step One-Pot Radiolabeling Strategy
by: Susann Schröder, et al.
Published: (2020-04-01)

Phosphodiesterase 4D Depletion/Inhibition Exerts Anti-Oncogenic Properties in Hepatocellular Carcinoma
by: Federica Ragusa, et al.
Published: (2021-05-01)

Phosphodiesterase 10 inhibition reduces striatal excitotoxicity in the quinolinic acid model of Huntington's disease
by: Carmela Giampà, et al.
Published: (2009-06-01)

Phosphodiesterase-4 Inhibition Reduces Cutaneous Inflammation and IL-1β Expression in a Psoriasiform Mouse Model but Does Not Inhibit Inflammasome Activation
by: Barbara Meier-Schiesser, et al.
Published: (2021-11-01)

Photon Correlation Spectroscopy and Applications
by: Chen, Sow-Hsin, et al.
Published: (2010)

Emerging Potential of the Phosphodiesterase (PDE) Inhibitor Ibudilast for Neurodegenerative Diseases: An Update on Preclinical and Clinical Evidence
by: Efthalia Angelopoulou, et al.
Published: (2022-12-01)

The Effects of Some Phosphodiesterase 5 Inhibitors on Oxidative Stress, VEGF, BMP 2 and 9 in the Liver Tissue of Ovariectomized Rats
by: Hamit Hakan Alp, et al.
Published: (2023-07-01)

Phosphodiesterase Inhibitors: Could They Be Beneficial for the Treatment of COVID-19?
by: Mauro Giorgi, et al.
Published: (2020-07-01)

Phosphodiesterase 5a Signalling in Skeletal Muscle Pathophysiology
by: Valeria De Arcangelis, et al.
Published: (2022-12-01)